Steve Race - Alert Sample

Alert Sample

View the Parallel Parliament page for Steve Race

Information between 15th September 2025 - 25th September 2025

Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.

Division Votes
15 Sep 2025 - Employment Rights Bill - View Vote Context Steve Race voted Aye - in line with the party majority and in line with the House One of 300 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 328 Noes - 160
15 Sep 2025 - Employment Rights Bill - View Vote Context Steve Race voted Aye - in line with the party majority and in line with the House One of 303 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 314 Noes - 178
15 Sep 2025 - Employment Rights Bill - View Vote Context Steve Race voted Aye - in line with the party majority and in line with the House One of 304 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 327 Noes - 164
15 Sep 2025 - Employment Rights Bill - View Vote Context Steve Race voted Aye - in line with the party majority and in line with the House One of 301 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 329 Noes - 163
15 Sep 2025 - Employment Rights Bill - View Vote Context Steve Race voted Aye - in line with the party majority and in line with the House One of 300 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 326 Noes - 160
15 Sep 2025 - Employment Rights Bill - View Vote Context Steve Race voted Aye - in line with the party majority and in line with the House One of 300 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 316 Noes - 172
15 Sep 2025 - Employment Rights Bill - View Vote Context Steve Race voted Aye - in line with the party majority and in line with the House One of 300 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 330 Noes - 158
15 Sep 2025 - Employment Rights Bill - View Vote Context Steve Race voted Aye - in line with the party majority and in line with the House One of 302 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 330 Noes - 161
15 Sep 2025 - Employment Rights Bill - View Vote Context Steve Race voted Aye - in line with the party majority and in line with the House One of 302 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 330 Noes - 161
15 Sep 2025 - Employment Rights Bill - View Vote Context Steve Race voted Aye - in line with the party majority and in line with the House One of 301 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 316 Noes - 161
15 Sep 2025 - Employment Rights Bill - View Vote Context Steve Race voted Aye - in line with the party majority and in line with the House One of 304 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 332 Noes - 160
15 Sep 2025 - Employment Rights Bill - View Vote Context Steve Race voted Aye - in line with the party majority and in line with the House One of 302 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 318 Noes - 170
16 Sep 2025 - Sentencing Bill - View Vote Context Steve Race voted Aye - in line with the party majority and in line with the House One of 278 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 340 Noes - 77
16 Sep 2025 - Sentencing Bill - View Vote Context Steve Race voted No - in line with the party majority and in line with the House One of 277 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 78 Noes - 292

Written Answers
Development Aid: Nutrition Asked by: Steve Race (Labour - Exeter) Wednesday 17th September 2025 Question to the Foreign, Commonwealth & Development Office: To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what estimate he has made of the level of therapeutic food procured through UK Overseas Development Assistance (a) directly by the Government and (b) by third party partners, in the latest year for which information is available. Answered by Chris Elmore - Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office) The Foreign, Commonwealth and Development Office (FCDO) does not directly procure therapeutic foods and does not currently hold data on the quantity of therapeutic foods procured by third-party partners using FCDO funds. Therapeutic foods are primarily procured as part of nutrition-related humanitarian programming. Expenditure on nutrition-related humanitarian programming is captured in the FCDO's annual nutrition accountability reports, which are published 18 months in arrears. The most recent report covers spend from 2022, totalling £238.5 million. This figure which includes funding for food assistance and therapeutic foods, should be viewed as a proxy indicator of the level of investment in such products, rather than a direct measure of procurement. Data on nutrition-related spend for 2023 will be published in Autumn 2025.

Written Answers

Development Aid: Nutrition
Asked by: Steve Race (Labour - Exeter)
Wednesday 17th September 2025

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what estimate he has made of the level of therapeutic food procured through UK Overseas Development Assistance (a) directly by the Government and (b) by third party partners, in the latest year for which information is available.

Answered by Chris Elmore - Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)

The Foreign, Commonwealth and Development Office (FCDO) does not directly procure therapeutic foods and does not currently hold data on the quantity of therapeutic foods procured by third-party partners using FCDO funds.

Therapeutic foods are primarily procured as part of nutrition-related humanitarian programming. Expenditure on nutrition-related humanitarian programming is captured in the FCDO's annual nutrition accountability reports, which are published 18 months in arrears. The most recent report covers spend from 2022, totalling £238.5 million. This figure which includes funding for food assistance and therapeutic foods, should be viewed as a proxy indicator of the level of investment in such products, rather than a direct measure of procurement. Data on nutrition-related spend for 2023 will be published in Autumn 2025.

Steve Race - Select Committee Information

Calendar
Tuesday 14th October 2025 9 a.m. Science, Innovation and Technology Committee - Oral evidence Subject: Innovation showcase View calendar - Add to calendar

Select Committee Documents
Wednesday 3rd September 2025 Oral Evidence - ARIA, and ARIA Science, Innovation and Technology Committee
Tuesday 16th September 2025 Oral Evidence - DSIT, Office for Life Sciences, and Department of Health and Social Care (DHSC) Science, Innovation and Technology Committee
Tuesday 16th September 2025 Oral Evidence - MSD, ABPI (The Association of the British Pharmaceutical Industry), and AstraZeneca Science, Innovation and Technology Committee

Select Committee Inquiry
2 Oct 2025 Life sciences investment Science, Innovation and Technology Committee (Select) Not accepting submissions With MSD cancelling its £1 billion ongoing manufacturing site in Kings Cross, AstraZeneca pausing its £200 million investment in its Cambridge site, and the latter upgrading its US listing, the Science, Innovation and Technology Committee is launching a call for evidence on UK life sciences competitiveness. This follows an initial emergency session, where it heard from representatives from MSD and AstraZeneca, as well as the ABPI, and from officials and ministers, including Minister for Science, Research and Innovation, Patrick Vallance. The call for written evidence will examine the competitiveness of the UK’s life sciences sector, barriers to innovation for medicines in the UK, issues with pricing uptake and access, and the impact of other countries’ policies.

Select Committee Inquiry

2 Oct 2025
Life sciences investment
Science, Innovation and Technology Committee (Select)
Not accepting submissions

With MSD cancelling its £1 billion ongoing manufacturing site in Kings Cross, AstraZeneca pausing its £200 million investment in its Cambridge site, and the latter upgrading its US listing, the Science, Innovation and Technology Committee is launching a call for evidence on UK life sciences competitiveness.

This follows an initial emergency session, where it heard from representatives from MSD and AstraZeneca, as well as the ABPI, and from officials and ministers, including Minister for Science, Research and Innovation, Patrick Vallance.

The call for written evidence will examine the competitiveness of the UK’s life sciences sector, barriers to innovation for medicines in the UK, issues with pricing uptake and access, and the impact of other countries’ policies.